You are here

Risperdal

J&J Will Pay $181 Million To Settle Risperdal Ad Claims

Bloomberg

Fri, 08/31/12 - 12:29 pm

J&J faces new marketing probes as Risperdal settlement nears

Fierce Pharma

Tue, 08/7/12 - 12:49 pm

Relieva Stratus MicroFlow Spacer

Johnson & Johnson says it has "agreement in principle'' with Justice officials over inproper marketing of Risperdal and other drugs

Star Ledger, NJ

Fri, 08/3/12 - 10:19 am

J&J Appeals $1.2 Billion Arkansas Risperdal Ruling

Bloomberg

Sat, 07/21/12 - 11:53 am

Report: J&J will pay as much as $2.2B to resolve investigation of Risperdal marketing

Yahoo/AP

Fri, 07/20/12 - 10:28 am

J&J close to settling with DOJ over marketing-WSJ

Reuters

Thu, 06/21/12 - 07:36 am

J&J Said To Pay $2.2 Billion To End Risperdal Sales Probe

Bloomberg

Mon, 06/11/12 - 10:48 am

Johnson & Johnson Will Tumble On Risperdal Lawsuit, Bad PR

Seeking Alpha

Thu, 04/19/12 - 10:41 am

Arkansas judge fines J&J $1.1B in Risperdal case

Yahoo/AP

Wed, 04/11/12 - 12:00 pm

J&J’s Marketing of Risperdal Violated Law, Arkansas Jury Rules

Bloomberg

Wed, 04/11/12 - 09:31 am

Closing arguments set in Arkansas trial over J&J subsidiary's antipsychotic drug Risperdal

Yahoo/AP

Tue, 04/10/12 - 09:31 am

J&J Goes Back To Texas Court Over Risperdal

Pharmalot

Mon, 03/26/12 - 12:43 pm

J&J Said to Face Demand to Raise Risperdal Accord Offer by $800 Million

Bloomberg

Mon, 03/12/12 - 05:45 pm

U.S. nixes tentative $1 bln settlement with J&J -WSJ

Reuters

Sat, 03/10/12 - 04:08 pm

Some antipsychotics raise risks of death in dementia patients - study

Pharma Times, UK

Fri, 02/24/12 - 11:30 am

Bristol-Myers Squibb

J&J’s Risperdal Wasn’t Factor in Man’s Diabetes, Jury Rules

Bloomberg

Thu, 02/16/12 - 05:24 pm

J&J Hid Risperdal Studies to Boost Drug Sales, Lawyer Says

Bloomberg Businessweek

Fri, 02/3/12 - 09:48 am

J. & J. to Pay $158 Million to End Suit Filed by Texas

New York Times

Sat, 01/21/12 - 01:15 pm

J&J to pay $158 million to settle Risperdal case

Markewatch

Thu, 01/19/12 - 12:03 pm

J&J Hid Risperdal Studies on Diabetes Risk From Regulators, Witness Says

Bloomberg

Thu, 01/19/12 - 10:37 am

Pages